U.S. Supreme Court Declines J&J Appeal of $70M Risperdal Verdict
Johnson & Johnson is out of options after the U.S. Supreme Court declined to hear the pharmaceutical company’s appeal of a $70 million Risperdal verdict. In the cases of Yount vs. Janssen Pharmaceuticals, the 2019 Superior Court of Pennsylvania ruling stands. Yount’s doctor prescribed Risperdal off-label to address behavioral problems associated with autism when he […]
Trump’s out of office. Allegations of his admission fraud still stand
Stephen Sheller, founder of Sheller P.C., and Eric Orts, Guardsmark Professor at the Wharton School at the University of Pennsylvania, penned a second request to the university’s administration for a formal investigation into allegations former President Trump committed admission fraud. Full letter below published as a guest column in The Daily Pennsylvanian. Stephen Sheller and Eric Orts’ previous letters […]
Stephen Sheller Honored as The Legal’s 2020 Pennsylvania Trailblazer
2020 Pennsylvania Trailblazers brought to you by The Legal Intelligencer Watch: Deadly Drugs – Johnson & Johnson’s Risperdal
Sheller 11th Street Family Health Supports Alumni Turkey Drive
The Stephen and Sandra Sheller 11th Street Family Health Services of Drexel University is one of the many ways that the Sheller family gives back to the community. Since the health center’s inception in 1996, it has been a community partner helping Drexel Alumni distribute holiday meals to those in need. Drexel’s Annual Holiday Charity […]
Sheller Gives Presentations on Risperdal and Opioid Litigation
Stephen A. Sheller, founder of Sheller PC, is often sought for his expertise in litigation against pharmaceutical manufacturers whose products cause harm to consumers. He recently has one of few private law firms chosen to work with the City of Philadelphia in opioid litigation. In October 2019 Sheller was an invited speaker at two conferences. October 12, 2019 “Big […]
$8 Billion Verdict: Jury decides J&J should pay in Risperdal case
October 9, 2019: Late yesterday a Philadelphia jury rendered an $8 billion punitive damages verdict against pharmaceutical company Johnson & Johnson for illegally marketing the antipsychotic drug Risperdal, putting young boys at risk for developing female-sized breast tissue. The condition, gynecomastia, is irreversible. “The conduct the jury saw in the courtroom was clear and convincing that J&J disregarded the […]
Opioid Drugmakers May Be Liable Under Consumer Protection Laws
Philadelphia District Attorney Larry Krasner has been given approval by a state judge to move forward with with action against drugmakers and distributors for illegal marketing and sales of opioid painkillers resulting in a nationwide epidemic. The suit, a first of its kind, brings claims under Pennsylvania’s Unfair Trade Practices and Consumer Protection Law. The UTPCPL bans […]
Jury May Decide Risperdal Time Bar
Two cases in front of the Pennsylvania Supreme Court could result in 40% of the over 7,000 Risperdal cases being time barred from moving forward. The Pennsylvania docket for Risperdal cases has grown significantly in the last few years. The Pennsylvania Supreme Court is being asked to reconsider two lower court rulings that began the […]
Temple Law Honors Sheller with Doctor of Humane Letters
Attorney Stephen Sheller, founder of Sheller PC, was honored with a doctor of humane letters degree at Temple University’s Beasley School of Law 2019 Commencement Ceremony on May 16. The Beasley School of Law celebrates Stephen A. Sheller, founding and managing partner of Sheller, P.C. and a passionate advocate for underdog clients. His philanthropic support […]
April 23rd, Book Signing: Big Pharma Big Greed
When: Tuesday, April 23, 2019 Time: 5:30 PM Location: Shakespeare & Co., 1632 Walnut Street, Philadelphia, PA 19103 Description: Big Pharma, Big Greed: The Inside Story of One Lawyer’s Battle to Stem the Flood of Dangerous Medicines and Protect Public Health An update and expansion of Sheller’s previous book with Sidney Kirkpatrick “Pharmageddon: A […]